Bibliographic Info
GuidelineWHO guidelines for malaria, 30 November 2024.
Year of Publication2024
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
High
Artemisinin-based combination therapy Treat children and adults with uncomplicated P. falciparum malaria with one of the following ACTs*:
- artemether-lumefantrine (AL)
- artesunate-amodiaquine (AS+AQ)
- artesunate-mefloquine (ASMQ)
- dihydroartemisinin-piperaquine (DHAP)
- artesunate + sulfadoxine-pyrimethamine (AS+SP)
- artesunate-pyronaridine (ASPY) (2022)
Notes and Remarks
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
WHO guidelines for malaria, 25 November 2022.
Year2022
InstitutionWorld Health Organization
Guideline
WHO guidelines for malaria, 16 October 2023.
Year2023
InstitutionWorld Health Organization
Guideline
WHO Guidelines for malaria, 14 March 2023
Year2023
InstitutionWHO